Common acquired causes of thrombosis in children

Jaszianne Tolbert1, Shannon L Carpenter

  • 1Division of Pediatric Hematology/Oncology/BMT, Children's Mercy Hospitals and Clinics, Kansas City, MO, USA.

Insights

Pediatric venous thromboembolism is rare but serious. Risk factors include cancer and cardiac disease, yet acquired thrombophilia studies and optimal treatments for children are limited, often relying on adult data.

Area of Science:

  • Pediatric Hematology
  • Pediatric Thrombosis
  • Medical Literature Review

Background:

  • Venous thromboembolism (VTE) is uncommon in children compared to adults.
  • Established risk factors for pediatric VTE include cancer, cardiac disease, antiphospholipid antibodies, and indwelling catheters.
  • Limited research exists on acquired thrombophilia in pediatric populations.

Purpose of the Study:

  • To review the existing literature on thrombophilia in children.
  • To explore the relationship between childhood cancer, cardiac disease, antiphospholipid antibody syndrome, and thrombosis.
  • To identify gaps in knowledge regarding pediatric VTE.

Main Methods:

  • Comprehensive literature search of studies on pediatric thrombophilia.
  • Review of articles focusing on childhood cancer and thrombosis.
  • Examination of research on cardiac disease and thrombosis in children.
  • Analysis of studies concerning antiphospholipid antibody syndrome in pediatric patients.
  • Citation mining to identify additional relevant articles.

Main Results:

  • Studies investigating acquired thrombophilia in children are notably limited.
  • Current treatment protocols for pediatric VTE are primarily extrapolated from adult data.
  • Optimal therapeutic strategies for VTE in children remain undetermined.

Conclusions:

  • There is a significant need for more research into acquired thrombophilia in children.
  • Evidence-based guidelines for managing VTE in pediatric populations are lacking.
  • Further investigation is required to establish effective and specific treatments for pediatric venous thromboembolism.

Related Concept Videos

Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...